Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care Lepola, Ulla M.; Loft, Henrik; Reines, Elin Heldbo Lepola, Ulla M.; Loft, Henrik; Reines, Elin Heldbo Less International Clinical Psychopharmacology. 18(4):211-217, July 2003. Favorites PDF Get Content & Permissions Buy
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies Möller, Hans-Jürgen; Llorca, Pierre-Michel; Sacchetti, Emilio; More Möller, Hans-Jürgen; Llorca, Pierre-Michel; Sacchetti, Emilio; Martin, Stephen D; Medori, Rossella; Parellada, Eduard; StoRMi Study Group Less International Clinical Psychopharmacology. 20(3):121-130, May 2005. Abstract Abstract Favorites PDF Get Content & Permissions Buy
